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Abstract The lipid bilayer is the diffusion barrier of biological
membranes. Highly protective membranes such as the blood–
brain barrier (BBB) are reinforced by ABC transporters such as
P-glycoprotein (MDR1, ABCB1) and multidrug resistance
associated proteins (MRPs, ABCCs). The transporters bind
their substrates in the cytosolic lipid bilayer leaflet before they
reach the cytosol and flip them to the outer leaflet. The large
majority of drugs targeted to the central nervous system
(CNS) are intrinsic substrates of these transporters. Whether
an intrinsic substrate can cross the BBB depends on whether
passive influx is higher than active efflux. In this paper, we
show that passive influx can be estimated quantitatively on the
basis of Stokesian diffusion, taking into account the ionization
constant and the cross-sectional area of the molecule in its
membrane bond conformation, as well as the lateral packing
density of the membrane. Active efflux by ABC transporters
was measured. The calculated net flux is in excellent
agreement with experimental results. The approach is exem-
plified with several drugs and fatty acid analogs. It shows that
compounds with small cross-sectional areas (AD<70 Å
2) and/
or intermediate or low charge exhibit higher passive influx
than efflux and, therefore, cross the BBB despite being
intrinsic substrates. Large (AD>70 Å
2) or highly charged
compounds show higher efflux than influx. They cannot cross
the BBB and are, thus, apparent substrates for ABC trans-
porters. The strict size and charge limitation for BBB
permeation results from the synergistic interaction between
passive influx and active efflux.
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Introduction
The limitation of intestinal barrier (IB) and blood–brain
barrier (BBB) permeation by the size and the charge of
molecules has long been observed (Didziapetris et al. 2003;
Fischer et al. 1998; Fischer et al. 1998; Gerebtzoff and Seelig
2006; Golin et al. 2003; Pauletti et al. 1997; Varma et al.
2005). For an understanding at the molecular level, the lipid
bilayer, the efflux transporters, and the permeating drugs
have to be characterized (Seelig and Gatlik-Landwojtowicz
2005). Most drugs reach the central nervous system (CNS)
by passive diffusion across the BBB. The BBB consists of
the endothelial cells of the blood capillaries in the brain that
have tight junctions that prevent paracellular diffusion.
Molecules targeted to the CNS, thus, have to cross the lipid
bilayer of the endothelial cell membrane. The barrier
property of the bilayer varies with the lipid composition
and the physical state of the lipids. Under physiological
conditions, the lipid bilayer is in the liquid crystalline state
and behaves like an optically uniaxial crystal with the optical
axis perpendicular to the surface of the bilayer. Lipid bilayers
are, thus, anisotropic systems in marked contrast to isotropic
organic solvents (e.g., octanol or hexadecane) often used as
membrane-mimicking systems.
Using solid state nuclear magnetic resonance (NMR)
techniques, a quantitative analysis of the molecular ordering
and dynamics of lipid bilayers became possible with a segment-
to-segment resolution. Well-defined conformations were ob-
served for the glycerol backbone and, to some extent, also for
the polar head groups. The packing of the fatty acyl chains is
best described in terms of a statistical order profile. For a given
J Mol Neurosci (2007) 33:32–41
DOI 10.1007/s12031-007-0055-y
A. Seelig (*)
Biophysical Chemistry, Biozentrum, University of Basel,
Klingelbergstrasse 70,
Basel, Switzerland
e-mail: Anna.Seelig@unibas.ch
membrane, the average order of the fatty acyl chains is
comparatively high, close to the head group region and
decreases toward the center of the membrane due to increasing
cis–trans isomerization of the C–C bonds (for reviews, see
Seelig 2002; Seelig 1980). The overall membrane order
increases with increasing percentage of lipids with small polar
head groups, such as phosphatidyethanolamine, sphingomye-
lin, or cholesterol, and decreases with increasing percentage of
lipids with unsaturated fatty acyl chains or with increasing
concentration of amphiphilic guest molecules (e.g., drugs;
Meier et al. 2006). Transmembrane proteins perfectly match
the lipid bilayer properties and barely influence the lipid order
(for reviews, see Seelig 2002; Seelig 1980).
A further possibility to characterize the properties of
lipid bilayer membranes is to assess their lateral lipid
packing density (πM) in comparison to the lateral packing
density or surface pressure of a lipid monolayer (Seelig
1987). Biological membranes exhibit a range of lateral
packing densities from πM≈28 mN/m for the IB, to πM≈
35 mN/m for the BBB, and πM≈45 mN/m for membranes
with a high content of phosphatidylethanolamines (Gatlik-
Landwojtowicz et al. 2006; Seelig 2006).
Using lipid monolayers as membrane model systems
revealed that the energy (ΔW) required for membrane
insertion is proportional to the lateral packing density of the
lipid layer (πM) and the cross-sectional area (AD) of the
penetrating compound (ΔW=ADπM; Boguslavsky et al.
1994). The lipid–water partition coefficient, therefore,
decreases exponentially with increasing membrane packing
density (πM) and increasing cross-sectional area (AD) of the
molecule (Boguslavsky et al. 1994; Fischer et al. 1998;
Gerebtzoff et al. 2004). As membrane insertion is the first
step in the process of passive diffusion, it also depends on
the two parameters (πM) and (AD) (Seelig and Gatlik-
Landwojtowicz 2005).
Molecules spanning half the lipid bilayer such as long-
chain fatty acids or lipid molecules reach the other side of
the membrane by a flip-flop mechanism rather than by
diffusion (for review, see Hamilton 1998; Hamilton and
Kamp 1999). However, like diffusion, flip-flop also
depends on the cross-sectional area of the compound and
the lateral packing density of the membrane as will be
discussed in more detail below.
The lipid bilayer is not only a barrier for large but also for
charged molecules. Although, molecules insert into the
membrane interface in their charged form, they can cross the
hydrophobic core of the membrane only in their uncharged
form (Kamp and Hamilton 1992; Saparov et al. 2006). A rare
exception is, e.g., the tetraphenylphosphonium ion that
exhibits a highly delocalized charge (Altenbach and Seelig
1985).
A calibration diagram for BBB permeation established
with 53 drugs with clinically well-tested ability to reach or
not to reach the CNS (Fischer et al. 1998) revealed a
limiting cross-sectional area of AD=73 Å
2 (rounded to AD≈
80 Å2) and a limiting ionization constant of pKa≈10 and
pKa≈4 for bases and acids, respectively. We recently
investigated a new set of compounds for BBB permeation
using an in silico procedure to calculate the cross-sectional
area of molecules in their membrane-bound conformation
(Gerebtzoff and Seelig 2006). This new approach revealed
a similar limiting cross-sectional area of AD≈70 Å2 for
BBB permeation. An analogous calibration for the IB
yielded a somewhat larger cut-off area of AD≈100 Å2, a
similar limiting ionization constant for bases and a lower
limiting ionization constant for acids due to the low pH in
the stomach (Fischer et al. 1998). The strict area and charge
limitation observed in the calibration diagrams cannot be
fully understood on the basis of the exponential area
dependence of membrane insertion (Boguslavsky et al.
1994; Fischer et al. 1998).
The barrier properties of membranes with protective
functions such as the BBB are reinforced by ABC transporters
including P-glycoprotein (Pgp, ABCB1), the recently identi-
fied breast cancer resistance protein (BCRP, ABCG2), and
several members of the multidrug resistance-associated
protein (MRPs, ABCCs) family (for review, see e.g., Begley
2004). Pgp is located in the apical membrane of the
endothelial cells. Its expression level varies with genetic
predisposition, age, food, and medication (Seelig and Gatlik-
Landwojtowicz 2005 and references therein). It reduces the
influx of a large variety of cationic or electrically neutral,
exogenous drugs and toxins into the CNS by binding them in
the inner, cytosolic leaflet of the lipid bilayer before they
reach the cytosol, and flipping them to the outer leaflet or
directly back into the blood using the energy of ATP
hydrolysis. If Pgp is absent as, e.g., in collies (Mealey et al.
2001) or knock-out mice (Schinkel et al. 1995), the CNS
concentration of certain drugs or toxins are much higher than
in individuals protected by Pgp. MRPs export negatively
charged and electrically neural compounds. The two efflux
proteins, Pgp and MRP1, recognize their substrates via
characteristic hydrogen bond acceptor patterns and share
electrically neutral substrates (Gatlik-Landwojtowicz et al.
2006; Seelig 1998; Seelig et al. 2000).
Net flux across a cell layer is generally assessed by
comparing basolateral-to-apical with apical-to-basolateral
transport in confluent cell monolayers (Burton et al. 2002).
The apparent or net transport (J) across the BBB is the sum
of passive influx (7 ) into the cytosol, active export (-V) by
ABC transporters from the apical membrane into the apical
medium, and passive bidirectional diffusion across the
basolateral membrane. Under the assumption that the
passive diffusion across the basolateral membrane is
identical in both directions, the net influx (J) across a cell
membrane can be estimated as the sum of passive influx
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(Φ) and active efflux (-V) across the apical membrane
(Seelig and Gatlik-Landwojtowicz 2005; Seelig 2006) (see
Fig. 1). We will show that net flux is membrane specific
and concentration dependent.
The aim of the present investigation was to deconvolve
passive influx (Φ) across the lipid bilayer and active efflux
(-V) by ABC transporters, and to assess the role of size
(Seelig and Gatlik-Landwojtowicz 2005) and charge for the
two processes. Passive influx was calculated on the basis of
Stokesian diffusion, taking into account the lateral packing
density of the membrane (Gatlik-Landwojtowiczet et al.
2006), as well as the charge and the cross-sectional area of
the compound in its membrane-bound conformation. The
latter was determined either by surface activity measure-
ments (Fischer et al. 1998) or by molecular modeling
(Gerebtzoff and Seelig 2006). Active efflux (-V) was
measured in MDR1-transfected mouse embryo fibroblasts,
exhibiting a similar expression level of ABC transporters as
the BBB. The concept is illustrated with 12 drugs that are
known to be intrinsic (although not necessarily apparent)
substrates for Pgp (Gatlik-Landwojtowicz et al. 2006), and
3 fatty acids that, in analogy to valproic acid (Ogawa et al.
2006) can be assumed to be intrinsic (although not
necessarily apparent) substrates for MRPs.
The analysis reveals that intrinsic substrates with small
cross-sectional areas (AD<70 Å
2) and low charge show
much higher passive influx than efflux and, therefore,
easily cross the BBB, whereas intrinsic substrates with
larger cross-sectional areas (AD>70 Å
2) and/or high charge
show lower influx than efflux and cannot reach the CNS.
The latter compounds are, thus, also apparent substrates at
the BBB.
Materials and Methods
Concept of Passive Diffusion
The diffusion of small hydrophobic non-electrolytes such as
benzene is too fast to be measured but was investigated by
molecular dynamics simulations (Bassolino-Klimas et al.
1993). After insertion into the well-ordered, highly packed
interfacial lipid region of the membrane (which was the rate-
limiting step), benzene was shown to move from one
packing defect to the next, whereby the rate of diffusion
increased with increasing cis–trans isomerization of the fatty
acyl chains toward the center of the membrane. The diffusion
of small hydrophilic compounds (e.g., acetamide or urea) can
in contrast be measured and was well described by simple
Stokesian diffusion (Finkelstein 1987). For a given mem-
brane, the permeability coefficients correlated linearly with
hexadecane–water partition coefficients. However, for mem-
branes of different lipid composition, permeability coeffi-
cients varied up to two orders of magnitude, decreasing with
increasing membrane packing density. These observations
show that the isotropic organic solvent hexadecane cannot
account for the lateral packing densities of the different lipid
membranes. A comparison of the permeability coefficients of
linear and branched compounds in a given membrane
suggested that the cross-sectional area rather than the
molecular weight of the molecule is relevant for diffusion.
Under physiological conditions, the diffusion of most
amphiphilic drugs is also too fast to be measured. In this
study, we calculate influx on the basis of Stokesian
diffusion, taking into account the cross-sectional area of
the drug in its membrane-bound conformation, as well as
the lateral packing density of the membrane (Seelig and
Gatlik-Landwojtowicz 2005).
Calculation of Passive Influx on the Basis of Stokesian
Diffusion Taking Into Account the Lateral Membrane
Packing Density
The permeability coefficient (P) is proportional to the
product of the lipid–water partition coefficient (γlw) and the
diffusion coefficient (D) of the drug and inversely propor-
tional to the thickness of the membrane (Δx)
P ¼ γ1w  D=Δx: ð1Þ
The lipid–water partition coefficient (γlw) used in the
context of membrane permeation is generally dimensionless
and is defined as
γ1w ¼ Cm

Ceq; ð2Þ
where Cm is the membrane and Ceq the aqueous concentra-
tion. The diffusion coefficient (D) is inversely related to the
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Figure 1 Cartoon of the endothelial cells that constitute the BBB.
Most drugs reach the cytosol or cross the cell layer by passive
diffusion (influx, Φ, is indicated by an arrow into cytosol). The apical
membrane harbors ATP transporters such as Pgp that efflux
compounds out of the apical membrane before they reach the cytosol
(efflux, −V, is indicated by an arrow out of the cell). The transport
across the basolateral membrane is assumed to be identical in both
directions (not indicated)
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radius (r) of the diffusing particle and the viscosity of the
membrane (η),
D ¼ kT= 6πηrð Þ: ð3Þ
The flux (Φ) is then defined as the product of the
permeability coefficient (P; Eq. 1) and the concentration
gradient between the intracellular and extracellular envi-
ronment (ΔC). If only the initial external aqueous concen-
tration (C) is considered, the flux can be expressed as
Φ ¼ C  P: ð4Þ
To take into account the lateral packing density of the
lipid membrane (πM) and the cross-sectional area of the drug
in its amphiphilic orientation (AD), we derived the lipid–
water partition coefficient (Klw) from the measured air–water
partition coefficient (Kaw) as
Klw ¼ Kaw  eπMAD=kT; ð5Þ
where kT is the thermal energy (Fischer et al. 1998). The
dimensionless lipid–water partition coefficient (γlw) is then
transformed to the lipid–water partition coefficient (Klw)
with the dimension [M −1],
g1w ¼ b  K1w; : ð6Þ
where b is the correction factor with the dimension [mol/l].
If we assume for simplicity that one mole of lipid
corresponds approximately to 1 l of lipid, the correction
factor is b≈1.Combining Eqs. 5 and 6 yields
γ1w ¼ b  Kaw  eπMAD=kT : ð7Þ
Since the cross-sectional area rather than the molecular
weight was shown to be relevant for membrane insertion
(Boguslavsky et al. 1994; Fischer et al. 1998) and membrane
permeation (Finkelstein 1987), we used the molecular radius
(rD) derived from the cross-sectional area of the molecule in
its membrane-bond conformation (AD=π·rD
2) instead of the
molecular radius (r) approximated from the cube root of the
molecular weight (Finkelstein 1987) to calculate the diffu-
sion coefficient of a compound (Eq. 3) 1.
Combining Eqs. 1, 3, and 7, the permeability coefficient
(P) can then be expressed as
P ¼ κ  Kaw  eπM πr2Dð Þ=kT
.
rD; ð8Þ
where κ comprises the membrane thickness and the
viscosity,
κ ¼ b  kT
6πηΔx
: ð9Þ
The flux (Φ) is obtained by combining Eqs. 4 and 8:
Φ ¼ κ  C  Kaw  eπM πr2Dð Þ=kT
.
rD: ð10Þ
Equation 10 shows that the passive influx across the lipid
bilayer depends essentially on the packing density of the
membrane (πM) and on the air–water partition coefficient
(Kaw) and the radius of the drug (rD), in the case of electrically
neutral compounds (Seelig and Gatlik-Landwojtowicz 2005).
The role of charge for membrane binding and permeation The
fraction of the non-ionized form of bases (fA) and acids
(fAH) at a particular pH that is able to cross the membrane
by passive diffusion is calculated as
fA ¼ A½ = HAþ½  þ A½ ð Þ ¼ 1þ 10 pKapH
 1 ð11Þ
and
fAH ¼ AH½ = Hþ½  þ A½ ð Þ ¼ 1þ 10pHpKa
 1
: ð12Þ
The partition coefficient of the permeating species of a
base and an acid (γ*lw) is
g*lw ¼ g lw  fA ð13Þ
and
g*lw ¼ g lw  fAH: ð14Þ
For many peptides (Beschiaschvili and Seelig 1992), most
drugs (Meier et al. 2006) and fatty acids (Cistola et al. 1986),
although not all compounds (e.g., tetracaine; Watts and Poile
1986), a pKa shift upon membrane binding has been observed.
This reflects the fact that the compounds are somewhat less
charged after insertion into the lipid bilayer membrane than in
aqueous solution. To illustrate, the effect data will be
calculated without and with a pKa shift (ΔpKa=0.5). If the
partition coefficient, glw (Eq. 2) is replaced by glw, the
permeability coefficient for cationic and anionic compounds
(P*) can then be expressed in analogy to Eq. 8 as
P ¼ κ  Kaw  e
πM πr2Dð Þ=kT
1þ 10pKapHð Þ 
1
rD
ð15Þ
and
P ¼ κ  Kaw  e
πM πr2Dð Þ=kT
1þ 10pHpKað Þ 
1
rD
; ð16Þ
respectively, and the flux (Φ*) for cationic and anionic
compounds can be given as
Φ ¼ C  κ  Kaw  e
πM πr2Dð Þ=kT
1þ 10pKapHð Þ 
1
rD
ð17Þ
and
Φ ¼ C  κ  Kaw  e
πM πr2Dð Þ=kT
1þ 10pHpKað Þ 
1
rD
; ð18Þ
respectively. For charged molecules, the flux, thus, depends
in addition on the ionization constant (pKa) of the
compound and the pH of the environment.
1 Equation 3 applies in principle to spherical particles. The diffusion
coefficient of elongated molecules with a small cross-sectional area
may, therefore, be somewhat overestimated.
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It has to be noted that the optimal therapeutic drug
concentration is often close to the concentration
corresponding to the inverse of the air–water partition
coefficient (C=1/Kaw; Seelig et al. 2000). The passive
influx (Φ) into the cell (Eq. 10) then simplifies to
Φ ﬃ κ  eπmAD=kT rD: ð19Þ
For uncharged drugs, it depends essentially on the radius
rD of the diffusing molecule (where AD=πrD
2) and the
packing density of the membrane (πM), and for charged
drugs, it depends in addition on the pKa of the drug and the
pH of the environment (Eqs. 17 and 18).
Measurement of Intrinsic Active Efflux
Intrinsic transport by Pgp is directly related to the rate of Pgp
activity (Gatlik-Landwojtowicz et al. 2006; Litman et al.
1997a), and intrinsic substrates can, therefore, be identified
by measuring the ATPase activity of Pgp. Whether one or
two ATP molecules are hydrolyzed per transport cycle is still
discussed (for review, see Higgins and Linton 2004). In this
study, we assumed that one ATP molecule is hydrolyzed (Al-
Shawi et al. 2003). Conventionally, Pgp activity has been
measured with inside-out plasma vesicles of MDR1-trans-
fected cells or with reconstituted proteoliposomes by
monitoring phosphate release upon ATP hydrolysis (Al-
Shawi et al. 2003; Ambudkar 1998; Litman et al. 1997b, c).
We have, for the first time, measured the activity of Pgp in
living MDR1-transfected cells as a function of concentration
by monitoring the extracellular acidification rate that reveals
the rate of ATP synthesis (Gatlik-Landwojtowicz et al. 2004;
Gatlik-Landwojtowicz et al. 2006; Landwojtowicz et al.
2002). Pgp activity as a function of drug concentration yields
generally bell-shaped activity profiles. They were evaluated
using modified Michaelis–Menten kinetics, assuming two
binding sites, one for activation and one for inhibition
(Litman et al. 1997a). At low-drug concentrations only one
binding site is occupied, and binding can be described by a
simple Michaelis–Menten kinetics:
V ¼ V0 þ Vmax  V0ð ÞC= C þ Kmð Þ; ð20aÞ
where V0 is the basal activity and Vmax is the maximum
activity; Km, the concentration of half-maximum activation
(Michaelis–Menten constant), and C, the concentration of the
drug in the aqueous environment. If data are derived from
extracellular acidification rate (ECAR) measurements (Gatlik-
Landwojtowicz et al. 2006), Eq. 20a is written as follows:
V ¼ V0 þ V 0max  V
0
0
 
C
.
C þ Kmð Þ ð20bÞ
where V
0
max is the maximum activity in living cells
overexpressing Pgp and V
0
0 the basal cellular activity,
including basal Pgp activity and basal cellular activity.
The rate of Pgp activity (log scale) decreases linearly
with increasing affinity of the compound to the transporter
(or decreasing negative free energy of binding from water
to the transporter). The free energy of binding from water to
the transporter is the sum of the free energy of membrane
partitioning and the free energy of binding of the drug from
the lipid membrane to the transporter. The latter is
proportional to the number of hydrogen bond acceptor
patterns in the drug (Seelig 2006).
Results and Discussion
Strict Size and Charge Limits for Drugs Observed
in Calibration Diagram for BBB Permeation
Injection of amphiphilic drugs into water leads to a
spontaneous partitioning between the bulk aqueous phase
and the air–water interface. At the air–water interface,
drugs organize themselves into a monolayer with the polar
head groups remaining in the aqueous environment and the
hydrophobic groups pointing toward the air. As the
dielectric constant of air (ɛ≈1) is similar to the dielectric
constant of the hydrocarbon region of the lipid membrane
(ɛ≈2), the air–water interface provides an excellent model
system for drug orientation at the lipid–water interface.
Drugs were, therefore, characterized by measuring the
surface pressure as a function of concentration (Gibbs
adsorption isotherm). This reveals the air–water partition
coefficient (Kaw), the critical micelle concentration (CMC),
and the cross-sectional area (AD) of the compound
perpendicular to the axis of amphiphilicity (Fischer et al.
1998). The latter corresponds to the cross-sectional area of
the membrane-bond conformation (Gerebtzoff and Seelig
2006). These three parameters were used to establish the
3D-calibration plot for BBB permeation (Fischer et al.
1998) displayed in Fig. 2. In this representation, the most
hydrophobic compounds are located in the left corner and
the most hydrophilic compounds in the upper right corner
of the xy-plane of the diagram. Compounds that are known
to reach the CNS are shown as open and compounds that
are known not to reach the CNS as filled symbols. It is
interesting to note that compounds with large cross-
sectional areas do not reach the CNS even if they are very
hydrophobic. Compounds measured previously (Fischer et
al. 1998) are indicated as circles, and compounds listed in
Table 1 are indicated as squares (Fig. 3). The 12 drugs
added to the original calibration diagram show the same
cutoff area for BBB permeation (AD≥70 Å2) as the
compounds investigated previously (Fischer et al. 1998,
Gerebtzoff and Seelig 2006). Diltiazem (12) is a borderline
case as will be shown in more detail in Fig. 4. For the sake
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of clarity, negatively charged compounds were not included
in Fig. 2.
Figure 3 displays the membrane-bound energy-minimized
structures of pyrene nonanoic acid and antroyloxystearic acid
in comparison to verapamil that is a typical Pgp substrate as
determined by molecular modeling (Gerebtzoff and Seelig
2006). The cross-sectional areas of the fatty acids in their
amphiphilic membrane-bound conformation clearly differ
because of the size and the position of the fluorescence
labels. Their calculated pKa values also differ as seen in
Table 1 due to the different inductive effects and the different
positions of the fluorescence labels.
Passive Influx Depends on the Size and the Charge
of the Molecule
Figure 4a and b displays passive influx (Φ*) as a function of
the cross-sectional area (AD) for the 12 compounds listed in
Table 1. Passive influx (Φ*) into the cell was calculated for
the concentration of half-maximum Pgp activity for each
compound according to Eq. 17 for the drugs and Eq. 18 for
the fatty acids. The charge of many drugs and fatty acids is
reduced upon membrane insertion (see “Material and
Methods”). To illustrate this effect, we calculated passive
influx without (Fig. 4a) and with (Fig. 4b) a pKa shift. The
further parameters used for the calculation of passive influx
are given in the legend to Fig. 4. For compounds with small
cross-sectional areas, e.g., the electrically neutral progester-
one (9), influx is orders of magnitude higher than for
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Figure 2 Three-dimensional calibration diagram for BBB permeation
for cationic and electrically neutral compounds of clinically well-
established ability to cross or not to cross the BBB. Compounds that
cross the BBB are indicated as open symbols and compounds that do
not cross the BBB as solid symbols. The air–water partition coefficient
(1/Kaw) and the critical micelle concentration (CMC) measured at
pH 7.4 are plotted in the x- and y-axis, respectively. The z-axis shows
the cross-sectional area (AD) of the drug in its membrane bond
conformation (Gerebtzoff and Seelig 2006). AD values were measured
at pH 7.4 and 8.0. To correct for charge repulsion effect values at
pH 8.0 are given, unless the area at pH 8.0 was larger than at pH 7.4,
which is a sign of drug association and concomitant pKa shifts
(Gerebtzoff et al. 2004). Data for compounds taken from Fischer et al.
(1998) are shown as circles; data for compounds listed in Table 1 are
shown as squares: amitriptyline (1), astemizole (2), chlorpromazine
(3), cis–flupenthixol (4), clomipramine (5), clonidine (6), cyclosporin
A (7), daunorubicin (8), desipramine (9), diazepam (10), dibucaine
(11), diltiazem (12), fluoxetine (13), hydroxizine (14), imipramine
(15), lidocaine (16), loperamide (17), mequitazine (18), noxiptilip
(19), perphenazine (20), progesterone (21), promazine (22), prom-
ethazine (23), reserpine (24), tamitinol (25), terfenadine (26),
thioridazine (27), trifluoperazine (28), triflupromazine (29), verapamil
(30), and zimelidine (31)
Table 1 The ionization constant (pKa), the air–water partition
coefficient (Kaw), the cross-sectional area (AD), the concentration of
half-maximum activation of Pgp (K1), and the maximum activity
(V1) of compounds 1–12 are measured values taken from Gatlik-
Landwojtowicz et al. (2006). The ionization constant (pKa) and the
cross-sectional area (AD) of the fatty acid analogs 13–15 are
calculated values as described in Gerebtzoff and Seelig (2006)
Number Compound pKa Kaw
[mM−1],
pH 7.4
AD [Å
2],
pH 8.0
K1
[μM]
V1
[fold]
1 Amitriptyline 9.4 7.1 52 6.4±
0.2
1.9±
0.01
2 Chlorpromazine 9.2 21.5 42 5.7±
0.0
2.0±
0.3
3 Cis–Flupenthixol 7.8 453 60 3.0±
1.8
1.4±
0.2
4 Cyclosporin A – 1,9952.6 140 0.02±
0.01
1.1±
0.1
5 Daunorubicin 8.4 588.8 106 0.6±
0.3
1.1±
0.05
6 Dibucaine 8.5 11.3 52 10.9±
1.0
2.0±
0.2
7 Diltiazem 8.9 26.9 70 3.5±
0.4
1.8±
0.2
8 Lidocaine 7.6 2.9 45 375.6±
91.3
1.5±
0.1
9 Progesterone – 157 40 5.0±
0.7
1.7±
0.2
10 Trifluoperazine 8.09 342 57.4 3.6±
0.0
1.6±
0.1
11 Triflupromazine 9.1 91.1 50 2.0±
0.5
1.7±
0.1
12 (R/S)–Verapamil 8.92 166.0 82 0.5±
0.1
1.6±
0.1
13 Palmitic acid 4.96 5000 27 0.2 ND
14 Pyrene nonanoic
acid
4.78 6000 43 0.2 ND
15 Antroyloxystearic
acid
2.84 7000 73 0.2 ND
The air–water partition coefficient (Kaw) for palmitic acid was
measured (X. Li-Blatter, unpublished results). The values of the two
analogs were estimated. The concentration of half-maximum activa-
tion of the hypothetical efflux transporter (MRP1) was estimated
according to Kaw·Km≈1 (see Seelig and Landwojtowicz 2000). The
rate of transport was assumed to be similar to Pgp.
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compounds with large cross-sectional areas, e.g., the electri-
cally neutral cyclosporin A (4). The influence of the pKa
value is seen, e.g., by the comparison of amitriptyline (1) and
dibucaine (6), which show the same cross-sectional area.
Amitriptyline, which has a higher pKa value than dibucaine,
is much more at risk to be exported than dibucaine.
Due to their different cross-sectional areas and pKa values,
the three fatty acids show distinctly different passive influx
rates as shown in Fig. 4. The uncharged fraction of
molecules exhibiting small cross-sectional areas, e.g., unla-
belled fatty acids, cross the membrane rapidly (for review,
see (Hamilton 1998; Hamilton and Kamp 1999), whereas
fatty acids labeled with fluorescent groups exhibiting larger
cross-sectional areas show a lower flip-flop rate. The
calculated passive influx of fatty acids (Fig. 3) correlates
well with measured flip-flop rates.
Active Efflux Depends on the Binding Affinity of the Drug
to the Transporter
Active efflux was measured in living MDR1 mouse embryo
fibroblasts (Gatlik-Landwojtowicz et al. 2006) and in the
corresponding inside-out membrane vesicles (Aanismaa and
Seelig 2007). The concentrations of half-maximum activity
were identical in the two systems. However, the rate of
intrinsic transport (or Pgp activity) was higher in living cells
than in inside-out plasma membrane vesicles (Aanismaa and
Seelig 2007). Active efflux (−V) as a function of the cross-
sectional area (AD) was included in Fig. 4. Active efflux (−V)
was calculated according to Eq. 20 using the maximum fold
activity, V1 or (Vmax) measured in MDR1-transfected mouse
embryo fibroblasts (Gatlik-Landwojtowicz et al. 2006; see
Table 1). MRP activation as a function of concentrations has
not yet been measured to our knowledge for the fatty acids
given in Table 1. Because MRP and Pgp function in a similar
manner, it is reasonable to assume similar turnover numbers
for the two proteins.
Recent data (Aanismaa and Seelig 2007) show that the rate
of active efflux decreases exponentially with increasing
binding affinity of the drug from water to the transporter.
The binding affinity of the drug from water to the transporter
is the sum of the binding affinity of the drug from water to the
lipid membrane and the binding affinity from the lipid
membrane to the transporter (Gatlik-Landwojtowicz et al.
2006). The binding affinity from the lipid phase to the
transporter increases with the number and strength of
hydrogen bond acceptor groups that seem to interact with
numerous hydrogen bond donor groups in the transmembrane
domains of the transporter (Omote and Al-Shawi 2006; Seelig
et al. 2000). For the present set of compounds, the number of
hydrogen bond acceptor groups per drug increases with the
cross-sectional area of the drug (Gatlik-Landwojtowicz et al.
2006; Seelig and Gatlik-Landwojtowicz 2005). The plot of
active efflux (−V) (log scale) as a function of the cross-
sectional area (AD) is, therefore, approximately linear as seen
in Fig. 4 (stars). In contrast to passive influx that decreases
Figure 3 Pyrene nonanoic acid (14), antroyloxystearic acid (15), and verapamil (12) (for number see Table 1). The molecules are shown in their
membrane-bound amphiphilic conformation as described in Gerebtzoff and Seelig (2006)
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with increasing cross-sectional area and charge, neither the
cross-sectional area (Seelig and Gatlik-Landwojtowicz 2005)
nor charge (e.g., Omote and Al-Shawi 2002) hinder active
efflux by Pgp and MRP, provided the molecules can reach the
inner leaflet of the lipid membrane. This suggests that the
efflux pathway through the protein is significantly more
flexible and polar than the influx pathway across the lipid
bilayer membrane.
Apparent or Net Flux is the Sum of Passive Influx
and Active Efflux
Apparent or net transport (J) across a cell membrane can be
estimated as the sum of passive influx (Φ) (or Φ*) and
active efflux (−V):
J ¼ Φ V : ð21Þ
According to Eq. 21, apparent export is only observed if
the value of active efflux (−V) is higher than the value of
passive influx (Φ) or (Φ*). The comparison of passive influx
(Φ*) and active efflux (−V) (both given in the same units) is
seen in Fig. 4a and b. Compounds with high influx (Φ*»108
molecules s−1 cell−1) are represented as open symbols and
compounds with low influx (Φ*«108 molecules s−1 cell−1) as
filled symbols. It is evident that compounds with low charge
and/or small cross-sectional area (AD<70 Å
2) generally
exhibit significantly higher passive influx (Φ*) than active
efflux (−V), whereas large or highly charged compounds
generally exhibit lower influx than efflux. The compounds,
chlorpromazine, cis–flupenthixol, dibucaine, lidocaine, pro-
gesterone, trifluoperazine, and triflupromazine, thus, cross
the membrane barrier despite being intrinsic Pgp substrates,
whereas cyclosporin A, daunorubicin, and verapamil are
clear apparent substrates that do not reach the CNS in
significant concentrations. Amitriptyline and diltiazem are
borderline compounds. Without taking into account a pKa shift
(Fig. 4a), they are predicted to be apparent Pgp substrates; if a
pKa shift is taken into account, they seem to reach the CNS at
low concentrations (Fig. 4b). The present simple prediction of
apparent substrates perfectly agrees with biological results at
the BBB (for amitriptyline and cyclosporin A, Thuerauf and
Fromm 2006; for daunorubicin, Zhao et al. 2002; and for
diltiazem and verapamil, Pani et al. 1990). Not only the
twelve drugs but also the three fatty acids show distinctly
different passive influx rates due to their different cross-
sectional areas and different pKa values. The two slimmer
molecules are likely to reach the CNS by passive diffusion
despite eventually being intrinsic substrates of MRPs,
whereas antroyloxystearic acid is likely to be an apparent
substrate and is, therefore, unlikely to reach the CNS.
The strict area and charge limitations observed in BBB and
IB calibration diagrams (Fischer et al. 1998; Fischer et al.
1998; Gerebtzoff and Seelig 2006) can be explained on the
basis of Fig. 4, which reveals that if a certain charge and size
limit is reached, influx (Φ) becomes lower than efflux (−V).
If the membrane exhibits a lower lateral packing density as,
e.g., the IB, the limiting cross-sectional area is larger
(Fischer et al.1998).
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Figure 4 a, b Passive influx (Φ*) of drugs (filled and open circles)
and fatty acids (filled and open triangles) and active efflux (−V) of
drugs (asterisk) by Pgp and of fatty acids (open stars) by MRPs
plotted as a function of the molecular cross-sectional area (AD). a
Influx was calculated taking into account no pKa shift upon drug
binding to the lipid membrane. b Influx was calculated taking into
account a pKa shift (ΔpKa=0.5) that reduces the charge of all
compounds upon membrane binding. Compounds with high influx
(Φ*>108 molecules s−1 cell−1) are represented as open symbols and
compounds with low influx (Φ*<108 molecules s−1 cell−1) as filled
symbols. The latter are apparent substrate for efflux transporters
(generally called “substrates”). The concentration chosen for these
calculations was the concentration of half-maximum transporter activity
(K1). It should be noted that the product of the air–water partition
coefficient (Kaw) and the concentration of half-maximum activation
(Km) is close to one (Kaw Km ≈ 1) (Seelig and Landwojtowicz 2000).
The drug concentration (C=1/Kaw), thus, corresponds approximately to
the concentration of half-maximum transporter activation (K1). Further
parameters used are the thickness, Δx=50 Å; the viscosity, η=1P; and
the packing density πM=35 mN/m (Seelig and Gerebtzoff 2006) of the
membrane and the lipidmembrane surface area per cellAlip=2.26·10
−7 cm2.
Compounds are numbered as in Table 1
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Conclusions
Three-dimensional calibration diagram for BBB permeation
established previously using the cross-sectional area (AD), the
air–water partition coefficient (Kaw), and the critical micelle
concentration (CMCD) as parameters (Fischer et al. 1998;
Gerebtzoff and Seelig 2006; Seelig et al. 1994) revealed a
limiting cross-sectional area (AD=70 Å
2). In addition a
limiting ionization constant (pKa≤4 for acids and pKa≥10
for bases) was observed. Incorporation of additional com-
pounds into the original 3D calibration diagram corroborated
the limiting values for BBB permeation. To rationalize the
strict area and charge limitation at the BBB, we investigated
the relationship between passive influx (Φ) and active efflux
by ABC transporters and determined net influx (J) as the
sum of the two. Passive influx (Φ) was calculated on the
basis of Stokesian diffusion, taking into account the air–
water partition, the cross-sectional area of the membrane-
bound conformation, and the ionization constant of the
compound, as well as the lateral packing density of the
membrane. Active efflux across the BBB was measured in
MDR1-transfected mouse embryo fibroblasts, which reveal a
Pgp expression level comparable to that of the BBB. Active
efflux depends on the affinity of the substrate to the
transporter, which in turn, correlates with the number and
strength of hydrogen bond interactions between the substrate
and the transporter. While passive influx (Φ) changes by
several orders of magnitude with the size and the charge of
the molecule, active efflux (−V) changes by less than one
order of magnitude for a given cell line. As long as
molecules are small (and influx is high), active transport
remains furtive. It becomes apparent only if molecules
exhibit a large cross-sectional area or a high charge and
efflux (−V) start to be larger than influx (Φ). The cross-
sectional area (AD) and the charge (pKa), therefore, dominate
the net flux (J) of drugs across the BBB. Whether a
compound is a substrate for the efflux transporters Pgp and
MRP1, however, not only depends on the characteristics of
the compound but also on the packing density of the lipid
membrane and the expression level of the transporters.
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